West Pharmaceutical Services, Inc. (WST)

WST Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	3,074	2,893	2,950	2,887	2,832
Revenue Growth (YoY)	6.25%	-1.92%	2.18%	1.95%	31.89%
Cost of Revenue	1,970	1,895	1,820	1,751	1,654
Gross Profit	1,104	998.5	1,130	1,136	1,178
Selling, General & Admin	388.7	334.9	354.1	316	356.3
Research & Development	74.3	69.1	68.4	58.5	52.8
Other Operating Expenses	28.3	0.9	1.3	-2.1	-
Operating Expenses	491.3	404.9	423.8	372.4	409.1
Operating Income	612.7	593.6	706.2	763.8	768.6
Interest Expense	-	-3	-9	-7.9	-8.2
Interest & Investment Income	17	19.6	28	5.1	1
Earnings From Equity Investments	14.4	14.7	17.7	20.7	20.1
Currency Exchange Gain (Loss)	-	-10.2	-9.4	4.1	1.4
Other Non Operating Income (Expenses)	-1	-	-	-	-
EBT Excluding Unusual Items	643.1	614.7	733.5	785.8	782.9
Merger & Restructuring Charges	-23.3	-2.1	2	-23.8	-2.2
Gain (Loss) on Sale of Investments	-4.5	-0.3	-4.3	-3.5	-4.3
Gain (Loss) on Sale of Assets	-	-	-11.6	-	-
Asset Writedown	-	-7	-5.3	-2.7	-4.1
Legal Settlements	-	-	3.8	-	-
Other Unusual Items	-	-5.1	-2.4	-55.2	-3.3
Pretax Income	615.3	600.2	715.7	700.6	769
Income Tax Expense	121.6	107.5	122.3	114.7	107.2
Net Income	493.7	492.7	593.4	585.9	661.8
Net Income to Common	493.7	492.7	593.4	585.9	661.8
Net Income Growth	0.20%	-16.97%	1.28%	-11.47%	91.16%
Shares Outstanding (Basic)	72	73	74	74	74
Shares Outstanding (Diluted)	73	74	75	76	76
Shares Change (YoY)	-1.36%	-2.13%	-0.66%	-0.66%	0.66%
EPS (Basic)	6.83	6.75	7.99	7.88	8.90
EPS (Diluted)	6.79	6.69	7.88	7.73	8.67
EPS Growth	1.49%	-15.10%	1.94%	-10.84%	89.72%
Free Cash Flow	468.9	276.4	414.5	439.4	330.6
Free Cash Flow Per Share	6.45	3.75	5.50	5.80	4.33
Dividend Per Share	0.850	0.810	0.770	0.730	0.690
Dividend Growth	4.94%	5.20%	5.48%	5.80%	6.15%
Gross Margin	35.91%	34.51%	38.31%	39.36%	41.59%
Operating Margin	19.93%	20.52%	23.94%	26.46%	27.14%
Profit Margin	16.06%	17.03%	20.12%	20.29%	23.37%
Free Cash Flow Margin	15.25%	9.55%	14.05%	15.22%	11.68%
EBITDA	784.1	749	843.5	884.4	890.9
EBITDA Margin	25.51%	25.89%	28.59%	30.64%	31.46%
D&A For EBITDA	171.4	155.4	137.3	120.6	122.3
EBIT	612.7	593.6	706.2	763.8	768.6
EBIT Margin	19.93%	20.52%	23.94%	26.46%	27.14%
Effective Tax Rate	19.76%	17.91%	17.09%	16.37%	13.94%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q